Methods and formulations for the treatment of female sexual dysfunction
Details for Australian Patent Application No. 2002232759 (hide)
International Classifications
Event Publications
23 January 2003 Application Open to Public Inspection
Published as AU-B-2002232759
24 June 2004 Amendment Made
The nature of the amendment is: Amend the name of the applicant from Endeavor Pharmaceuticals to Endeavor Pharmaceuticals, Inc.
24 June 2004 Assignment before Grant
Endeavor Pharmaceuticals, Inc. The application has been assigned to Barr Laboratories, Inc.
11 May 2006 Application Accepted
Published as AU-B-2002232759
7 September 2006 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002232758-RECOMBINANT DNA VECTORS FOR EXPRESSION OF SOMATOTROPINS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser